Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil P Robertson

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Journal of Neurology|March 21, 2012
The C9ORF72 syndrome: implications for clinical practiceNeil P Robertson
Journal of Neurology|January 11, 2025
Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawnNeil P Robertson
Journal of Neurology|February 17, 2023
Advances in Tourette's syndromeNeil P Robertson
Journal of Neurology|June 28, 2018
Transmissible amyloid protein: evidence from iatrogenic CJDMo Hu, Neil P Robertson
Journal of Neurology|March 27, 2015
Pathophysiology of neuropsychiatric disorders: moving forwardGillian Ingram, Neil P Robertson
Journal of Neurology|February 18, 2014
MOG-IgG in neuromyelitis opticaSebastian Luppe, Neil P Robertson
Journal of Neurology|June 30, 2012
Understanding mechanisms and treatments for neuropathic diseaseKatharine Harding, Neil P Robertson
Journal of Neurology|June 20, 2024
Advances in the treatment of the muscular dystrophiesCallum Wood, Neil P Robertson
Journal of Neurology|June 13, 2015
Improving survival in amyotrophic lateral sclerosis: future treatments in a modern serviceJames Hrastelj, Neil P Robertson
Journal of Neurology|May 17, 2024
Diagnostic criteria for MOGADSophie Voase, Neil P Robertson
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neurology|March 21, 2012
The C9ORF72 syndrome: implications for clinical practiceNeil P Robertson
Journal of Neurology|January 11, 2025
Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawnNeil P Robertson
Journal of Neurology|February 17, 2023
Advances in Tourette's syndromeNeil P Robertson
Journal of Neurology|June 28, 2018
Transmissible amyloid protein: evidence from iatrogenic CJDMo Hu, Neil P Robertson
Journal of Neurology|March 27, 2015
Pathophysiology of neuropsychiatric disorders: moving forwardGillian Ingram, Neil P Robertson
Journal of Neurology|February 18, 2014
MOG-IgG in neuromyelitis opticaSebastian Luppe, Neil P Robertson
Journal of Neurology|June 30, 2012
Understanding mechanisms and treatments for neuropathic diseaseKatharine Harding, Neil P Robertson
Journal of Neurology|June 20, 2024
Advances in the treatment of the muscular dystrophiesCallum Wood, Neil P Robertson
Journal of Neurology|June 13, 2015
Improving survival in amyotrophic lateral sclerosis: future treatments in a modern serviceJames Hrastelj, Neil P Robertson
Journal of Neurology|May 17, 2024
Diagnostic criteria for MOGADSophie Voase, Neil P Robertson
Pageof 13